Before Moore, Schall, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary: The Board erred by finding method-claim steps connected by “and” to be conditional and by never explaining ...
In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. In the recent Federal Circuit decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS ...
“The insurance claim may comprise any of a claim against one or more of a health insurance, a worker compensation insurance, a liability insurance, a homeowner’s insurance, a property casualty ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
In an opinion of two factually similar cases, Akamai Technologies v. Limelight Networks and McKesson Technologies v. Epic Systems, consolidated as 692 F.3d 1301 (Fed. Cir. 2012), a split 6-5 U.S.
During the rapid development of the biotech industry in the nineties, large numbers of tests, research tools and assays were developed. Such inventions were primarily patent-protected using "method" ...
Molecular biomarkers, such as variations in genetic sequences, protein levels, or combinations of specific biochemical changes, are increasingly important to the emergence of personalized medicine.
The computer-implemented method of claim 1, wherein processing the claim to determine whether to continue the locked out state for the client device comprises: receiving user claim information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results